nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.0214	0.0214	CcSEcCtD
Betahistine—Dermatitis atopic—Doxorubicin—muscle cancer	0.0196	0.0196	CcSEcCtD
Betahistine—Erythema multiforme—Dactinomycin—muscle cancer	0.0183	0.0183	CcSEcCtD
Betahistine—Bronchospasm—Etoposide—muscle cancer	0.0173	0.0173	CcSEcCtD
Betahistine—Hallucination—Vincristine—muscle cancer	0.0172	0.0172	CcSEcCtD
Betahistine—Vasodilation procedure—Doxorubicin—muscle cancer	0.0165	0.0165	CcSEcCtD
Betahistine—Vasodilation—Doxorubicin—muscle cancer	0.0165	0.0165	CcSEcCtD
Betahistine—Ventricular extrasystoles—Doxorubicin—muscle cancer	0.0161	0.0161	CcSEcCtD
Betahistine—Ill-defined disorder—Dactinomycin—muscle cancer	0.0157	0.0157	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.0155	0.0155	CcSEcCtD
Betahistine—Malaise—Dactinomycin—muscle cancer	0.0152	0.0152	CcSEcCtD
Betahistine—Discomfort—Dactinomycin—muscle cancer	0.0142	0.0142	CcSEcCtD
Betahistine—Erythema multiforme—Etoposide—muscle cancer	0.0133	0.0133	CcSEcCtD
Betahistine—Convulsion—Vincristine—muscle cancer	0.0131	0.0131	CcSEcCtD
Betahistine—Immune system disorder—Etoposide—muscle cancer	0.0127	0.0127	CcSEcCtD
Betahistine—Anaphylactic shock—Vincristine—muscle cancer	0.0123	0.0123	CcSEcCtD
Betahistine—Nervous system disorder—Vincristine—muscle cancer	0.0121	0.0121	CcSEcCtD
Betahistine—Fatigue—Dactinomycin—muscle cancer	0.0119	0.0119	CcSEcCtD
Betahistine—Feeling abnormal—Dactinomycin—muscle cancer	0.0114	0.0114	CcSEcCtD
Betahistine—Ill-defined disorder—Etoposide—muscle cancer	0.0113	0.0113	CcSEcCtD
Betahistine—Malaise—Etoposide—muscle cancer	0.011	0.011	CcSEcCtD
Betahistine—Gastrointestinal disorder—Vincristine—muscle cancer	0.0106	0.0106	CcSEcCtD
Betahistine—Fatigue—Vincristine—muscle cancer	0.0106	0.0106	CcSEcCtD
Betahistine—Convulsion—Etoposide—muscle cancer	0.0106	0.0106	CcSEcCtD
Betahistine—Asthma—Methotrexate—muscle cancer	0.0105	0.0105	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.0103	0.0103	CcSEcCtD
Betahistine—Discomfort—Etoposide—muscle cancer	0.0103	0.0103	CcSEcCtD
Betahistine—Hypersensitivity—Dactinomycin—muscle cancer	0.0102	0.0102	CcSEcCtD
Betahistine—Confusional state—Etoposide—muscle cancer	0.0101	0.0101	CcSEcCtD
Betahistine—Anaphylactic shock—Etoposide—muscle cancer	0.00997	0.00997	CcSEcCtD
Betahistine—Asthenia—Dactinomycin—muscle cancer	0.00989	0.00989	CcSEcCtD
Betahistine—Tachycardia—Etoposide—muscle cancer	0.00973	0.00973	CcSEcCtD
Betahistine—Skin disorder—Etoposide—muscle cancer	0.00969	0.00969	CcSEcCtD
Betahistine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00961	0.00961	CcSEcCtD
Betahistine—Abdominal pain upper—Doxorubicin—muscle cancer	0.00961	0.00961	CcSEcCtD
Betahistine—Diarrhoea—Dactinomycin—muscle cancer	0.00943	0.00943	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00929	0.00929	CcSEcCtD
Betahistine—Abdominal distension—Doxorubicin—muscle cancer	0.00916	0.00916	CcSEcCtD
Betahistine—Asthma—Doxorubicin—muscle cancer	0.0091	0.0091	CcSEcCtD
Betahistine—Hypersensitivity—Vincristine—muscle cancer	0.00907	0.00907	CcSEcCtD
Betahistine—Dyspnoea—Etoposide—muscle cancer	0.00889	0.00889	CcSEcCtD
Betahistine—Somnolence—Etoposide—muscle cancer	0.00887	0.00887	CcSEcCtD
Betahistine—Asthenia—Vincristine—muscle cancer	0.00883	0.00883	CcSEcCtD
Betahistine—Vomiting—Dactinomycin—muscle cancer	0.00876	0.00876	CcSEcCtD
Betahistine—Rash—Dactinomycin—muscle cancer	0.00869	0.00869	CcSEcCtD
Betahistine—Gastrointestinal disorder—Etoposide—muscle cancer	0.00861	0.00861	CcSEcCtD
Betahistine—Fatigue—Etoposide—muscle cancer	0.0086	0.0086	CcSEcCtD
Betahistine—Diarrhoea—Vincristine—muscle cancer	0.00842	0.00842	CcSEcCtD
Betahistine—Feeling abnormal—Etoposide—muscle cancer	0.00822	0.00822	CcSEcCtD
Betahistine—Nausea—Dactinomycin—muscle cancer	0.00819	0.00819	CcSEcCtD
Betahistine—Dizziness—Vincristine—muscle cancer	0.00814	0.00814	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00804	0.00804	CcSEcCtD
Betahistine—Erythema multiforme—Methotrexate—muscle cancer	0.00795	0.00795	CcSEcCtD
Betahistine—Urticaria—Etoposide—muscle cancer	0.00792	0.00792	CcSEcCtD
Betahistine—Vomiting—Vincristine—muscle cancer	0.00783	0.00783	CcSEcCtD
Betahistine—Rash—Vincristine—muscle cancer	0.00776	0.00776	CcSEcCtD
Betahistine—Dermatitis—Vincristine—muscle cancer	0.00776	0.00776	CcSEcCtD
Betahistine—Headache—Vincristine—muscle cancer	0.00771	0.00771	CcSEcCtD
Betahistine—Immune system disorder—Methotrexate—muscle cancer	0.0076	0.0076	CcSEcCtD
Betahistine—Hypersensitivity—Etoposide—muscle cancer	0.00735	0.00735	CcSEcCtD
Betahistine—Nausea—Vincristine—muscle cancer	0.00731	0.00731	CcSEcCtD
Betahistine—Asthenia—Etoposide—muscle cancer	0.00716	0.00716	CcSEcCtD
Betahistine—Pruritus—Etoposide—muscle cancer	0.00706	0.00706	CcSEcCtD
Betahistine—Erythema multiforme—Doxorubicin—muscle cancer	0.00688	0.00688	CcSEcCtD
Betahistine—Diarrhoea—Etoposide—muscle cancer	0.00682	0.00682	CcSEcCtD
Betahistine—Ill-defined disorder—Methotrexate—muscle cancer	0.00679	0.00679	CcSEcCtD
Betahistine—Malaise—Methotrexate—muscle cancer	0.0066	0.0066	CcSEcCtD
Betahistine—Dizziness—Etoposide—muscle cancer	0.0066	0.0066	CcSEcCtD
Betahistine—Immune system disorder—Doxorubicin—muscle cancer	0.00658	0.00658	CcSEcCtD
Betahistine—Convulsion—Methotrexate—muscle cancer	0.00634	0.00634	CcSEcCtD
Betahistine—Vomiting—Etoposide—muscle cancer	0.00634	0.00634	CcSEcCtD
Betahistine—Rash—Etoposide—muscle cancer	0.00629	0.00629	CcSEcCtD
Betahistine—Dermatitis—Etoposide—muscle cancer	0.00628	0.00628	CcSEcCtD
Betahistine—Headache—Etoposide—muscle cancer	0.00625	0.00625	CcSEcCtD
Betahistine—Flatulence—Doxorubicin—muscle cancer	0.00625	0.00625	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00619	0.00619	CcSEcCtD
Betahistine—Discomfort—Methotrexate—muscle cancer	0.00616	0.00616	CcSEcCtD
Betahistine—Confusional state—Methotrexate—muscle cancer	0.00602	0.00602	CcSEcCtD
Betahistine—Anaphylactic shock—Methotrexate—muscle cancer	0.00597	0.00597	CcSEcCtD
Betahistine—Nausea—Etoposide—muscle cancer	0.00592	0.00592	CcSEcCtD
Betahistine—Ill-defined disorder—Doxorubicin—muscle cancer	0.00588	0.00588	CcSEcCtD
Betahistine—Nervous system disorder—Methotrexate—muscle cancer	0.00586	0.00586	CcSEcCtD
Betahistine—Skin disorder—Methotrexate—muscle cancer	0.0058	0.0058	CcSEcCtD
Betahistine—Malaise—Doxorubicin—muscle cancer	0.00572	0.00572	CcSEcCtD
Betahistine—Convulsion—Doxorubicin—muscle cancer	0.00549	0.00549	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00536	0.00536	CcSEcCtD
Betahistine—Discomfort—Doxorubicin—muscle cancer	0.00533	0.00533	CcSEcCtD
Betahistine—Dyspnoea—Methotrexate—muscle cancer	0.00533	0.00533	CcSEcCtD
Betahistine—Somnolence—Methotrexate—muscle cancer	0.00531	0.00531	CcSEcCtD
Betahistine—Dyspepsia—Methotrexate—muscle cancer	0.00526	0.00526	CcSEcCtD
Betahistine—Confusional state—Doxorubicin—muscle cancer	0.00522	0.00522	CcSEcCtD
Betahistine—Anaphylactic shock—Doxorubicin—muscle cancer	0.00517	0.00517	CcSEcCtD
Betahistine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00516	0.00516	CcSEcCtD
Betahistine—Fatigue—Methotrexate—muscle cancer	0.00515	0.00515	CcSEcCtD
Betahistine—Nervous system disorder—Doxorubicin—muscle cancer	0.00507	0.00507	CcSEcCtD
Betahistine—Tachycardia—Doxorubicin—muscle cancer	0.00505	0.00505	CcSEcCtD
Betahistine—Skin disorder—Doxorubicin—muscle cancer	0.00502	0.00502	CcSEcCtD
Betahistine—Feeling abnormal—Methotrexate—muscle cancer	0.00492	0.00492	CcSEcCtD
Betahistine—Urticaria—Methotrexate—muscle cancer	0.00475	0.00475	CcSEcCtD
Betahistine—Dyspnoea—Doxorubicin—muscle cancer	0.00461	0.00461	CcSEcCtD
Betahistine—Somnolence—Doxorubicin—muscle cancer	0.0046	0.0046	CcSEcCtD
Betahistine—Dyspepsia—Doxorubicin—muscle cancer	0.00455	0.00455	CcSEcCtD
Betahistine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00447	0.00447	CcSEcCtD
Betahistine—Fatigue—Doxorubicin—muscle cancer	0.00446	0.00446	CcSEcCtD
Betahistine—Hypersensitivity—Methotrexate—muscle cancer	0.0044	0.0044	CcSEcCtD
Betahistine—Asthenia—Methotrexate—muscle cancer	0.00429	0.00429	CcSEcCtD
Betahistine—Feeling abnormal—Doxorubicin—muscle cancer	0.00426	0.00426	CcSEcCtD
Betahistine—Pruritus—Methotrexate—muscle cancer	0.00423	0.00423	CcSEcCtD
Betahistine—Urticaria—Doxorubicin—muscle cancer	0.00411	0.00411	CcSEcCtD
Betahistine—Diarrhoea—Methotrexate—muscle cancer	0.00409	0.00409	CcSEcCtD
Betahistine—Dizziness—Methotrexate—muscle cancer	0.00395	0.00395	CcSEcCtD
Betahistine—Hypersensitivity—Doxorubicin—muscle cancer	0.00381	0.00381	CcSEcCtD
Betahistine—Vomiting—Methotrexate—muscle cancer	0.0038	0.0038	CcSEcCtD
Betahistine—Rash—Methotrexate—muscle cancer	0.00377	0.00377	CcSEcCtD
Betahistine—Dermatitis—Methotrexate—muscle cancer	0.00376	0.00376	CcSEcCtD
Betahistine—Headache—Methotrexate—muscle cancer	0.00374	0.00374	CcSEcCtD
Betahistine—Asthenia—Doxorubicin—muscle cancer	0.00371	0.00371	CcSEcCtD
Betahistine—Pruritus—Doxorubicin—muscle cancer	0.00366	0.00366	CcSEcCtD
Betahistine—Nausea—Methotrexate—muscle cancer	0.00355	0.00355	CcSEcCtD
Betahistine—Diarrhoea—Doxorubicin—muscle cancer	0.00354	0.00354	CcSEcCtD
Betahistine—Dizziness—Doxorubicin—muscle cancer	0.00342	0.00342	CcSEcCtD
Betahistine—Vomiting—Doxorubicin—muscle cancer	0.00329	0.00329	CcSEcCtD
Betahistine—Rash—Doxorubicin—muscle cancer	0.00326	0.00326	CcSEcCtD
Betahistine—Dermatitis—Doxorubicin—muscle cancer	0.00326	0.00326	CcSEcCtD
Betahistine—Headache—Doxorubicin—muscle cancer	0.00324	0.00324	CcSEcCtD
Betahistine—Nausea—Doxorubicin—muscle cancer	0.00307	0.00307	CcSEcCtD
